StockData

Indaptus Therapeutics, Inc. (INDP) stock

INDPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$3.32−0.13 (-3.77%)

Close on Nov 17, 2026Market cap $442.37MP/E –Yield –

Indaptus Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Indaptus Therapeutics

Indaptus Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Indaptus Therapeutics figures

See a number that looks wrong?